Project Grant R01AA031486
- Federal Project Grant Award Summary The University of New Mexico Health Sciences Center received a $120,558 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), awarded on March 9, 2026, with a completion date of January 31, 2030. This research initiative investigates the electrophysiological mechanisms underlying cognitive control deficits caused by prenatal alcohol exposure (PAE). The project combines translational...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Lovelace Biomedical Research Institute a Project Grant of $733,704 effective September 1, 2025, through June 30, 2030, under the Alcohol Research Programs (CFDA 93.273). The award funds a multimodal neuroimaging study examining the neurophysiological mechanisms underlying spatial navigation memory deficits in children and adolescents exposed to alcohol during prenatal development. The research will...
- This Project Grant award of $5,949,022, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID). The research, led by the Jackson Laboratory with sub-awards to Emory University, Rush...
- This Project Grant award of $223,932, obligated on August 31, 2025, supports neuroscience research conducted by Indiana University Indianapolis under the Alcohol Research Programs (CFDA 93.273), administered by the National Institute on Alcohol Abuse and Alcoholism. The research targets parvalbumin inhibitory interneurons to elucidate the neural circuit mechanisms underlying impulsivity and its relationship to genetic risk for excessive drinking. The project investigates how specific cell...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded The Children's Hospital of Philadelphia Research Institute a $534,000 Project Grant effective September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the lifespan effects of prenatal and perinatal opioid exposure on the brain's metabolic-epigenetic axis. The research addresses a critical gap in neuroprotective treatment development by examining how opioid exposure during fetal...
- Federal Project Grant Award Summary Baylor College of Medicine received a $151,040 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded December 9, 2025, with completion anticipated by August 31, 2028. This research project explores the role of hippocampal hypervascularization in Rett syndrome pathogenesis, a severe neurological disorder caused...
- Federal Grant Award Summary Texas A&M University System Health Science Center received a $146,100 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 1, 2025, through August 31, 2027. This award supports research investigating how paternal preconception alcohol consumption and maternal polysubstance use (specifically alcohol combined with cannabinoids) exacerbate behavioral deficits and alter...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Medical University of South Carolina a Project Grant of $459,707 on September 5, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct research on astrocyte physiology and its role in alcohol use disorder (AUD). The five-year project, extending through May 31, 2030, will investigate chronic intermittent ethanol (CIE) exposure-induced changes in the lateral orbitofrontal...
- The National Institute of Mental Health (NIMH) has awarded a $1,388,925 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco (UCSF) to conduct research on the role of vascular mural cells in the development of the blood-brain barrier. The key objectives of this 3-year grant are to: 1) Construct a spatiotemporal atlas of brain mural cells during development using single-cell RNA sequencing and tissue-based...
- The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples. The...
MOLECULAR TARGETING OF THE CEREBROVASCULATURE DURING PRENATAL ALCOHOL EXPOSURE - PROJECT SUMMARY FETAL ALCOHOL SPECTRUM DISORDERS (FASD) CONSTITUTE AN ARRAY OF NEUROCOGNITIVE AND BEHAVIORAL DEFICITS EXHIBITED BY INDIVIDUALS WHO EXPERIENCE SOME DISABILITY AS A RESULT OF PRENATAL ALCOHOL EXPOSURE (PAE). IN THE UNITED STATES, THE INCIDENCE OF FASD IS ESTIMATED TO BE 20-50/1,000 CHILDREN. WITH NO CURATIVE TREATMENTS AVAILABLE, IT IS OF PARAMOUNT IMPORTANCE TO CONSIDER FRESH PERSPECTIVES AND IMPROVE OUR UNDERSTANDING OF FACTORS DRIVING FASD-ASSOCIATED DEFICITS. MUCH RESEARCH HAS FOCUSED ON NEURONAL-SPECIFIC DEFECTS IN THE CENTRAL NERVOUS SYSTEM WITH LESS ATTENTION GIVEN TO THE VASCULAR COMPARTMENT AND IN PARTICULAR TO ENDOTHELIAL CELL-SPECIFIC DEFECTS MEDIATED BY PAE. CONSIDERING THE INTIMATE RELATIONSHIP BETWEEN THE DEVELOPING NEURONAL AND VASCULAR NETWORKS DURING EMBRYOGENESIS, IT IS LIKELY THAT ABNORMAL VASCULAR DEVELOPMENT CONTRIBUTES TO PAE-ASSOCIATED BRAIN PATHOLOGY. USING AN ESTABLISHED MOUSE MODEL OF MODERATE PAE, WE FOUND THAT MICRORNA (MIR)-150-5P WAS SIGNIFICANTLY INCREASED IN THE PAE EMBRYONIC CORTICES AND IN BRAIN MICROVASCULAR ENDOTHELIAL CELLS (BMVECS) ISOLATED FROM THOSE CORTICES COMPARED TO CONTROLS. MIR-150-5P IS A NEGATIVE REGULATOR OF ANGIOGENESIS AND THE BLOOD BRAIN BARRIER (BBB), AND ITS TARGETS INCLUDE ENDOTHELIAL-SPECIFIC TRANSCRIPTION FACTORS AND MATRIX METALLOPROTEINASES AS WELL AS ADHERENS AND TIGHT JUNCTION PROTEINS, WHICH WERE SIGNIFICANTLY REDUCED IN THE SAME TISSUES. ADDITIONALLY, WE FOUND THAT THE VASCULATURE OF PAE EMBRYONIC CORTICES DISPLAYED SIGNIFICANT ALTERATIONS INCLUDING REDUCTIONS IN VESSEL AREA AND VOLUME, THE MEAN DIAMETER OF BLOOD VESSELS, AND BBB INTEGRITY. INHIBITION OF MIR-150-5P OR OVEREXPRESSION OF ITS TARGETS RESTORED ANGIOGENESIS AND DECREASED PERMEABILITY OF BMVECS EXPOSED TO ALCOHOL. OUR LONG-TERM GOALS ARE TO DISCOVER NOVEL TARGETS AND DEVELOP STRATEGIES THAT MAY BE USEFUL FOR REVERSING OR ALLEVIATING THE ADVERSE CONSEQUENCES OF PAE. THE OVERALL OBJECTIVE OF THIS PROPOSAL IS TO IDENTIFY MOLECULAR MECHANISMS AND REGULATORS OF MIR-150-5P THAT LEAD TO ENDOTHELIAL CELL AND VASCULAR DYSFUNCTION, WHICH COULD BE HARNESSED AS POTENTIAL THERAPEUTIC TARGETS FOR IMPROVING PAE-MEDIATED EFFECTS. OUR SPECIFIC AIMS ARE TO FIRST INVESTIGATE THE MECHANISMS BY WHICH MIR-150-5P LEVELS ARE ENHANCED IN BMVECS, EXAMINING ITS TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL REGULATION. WE WILL THEN EVALUATE THE EFFECT OF MIR-150-5P ON THE MOLECULAR AND CELLULAR PROPERTIES OF BMVECS AND THE NEUROVASCULAR UNIT (NVU) FOLLOWING PAE, PRESERVING PHYSIOLOGICAL CONTEXT AND SPATIAL INFORMATION. FINALLY, WE WILL EXAMINE WHETHER THE MIR-150-5P-MEDIATED DEVIATIONS IN VASCULAR MORPHOLOGY AND FUNCTION PERSIST INTO POSTNATAL LIFE FOLLOWING PAE, USING TISSUE CLEARING COMBINED WITH FLUORESCENCE MICROSCOPY OF THE CORTICAL VASCULATURE AS WELL AS FUNCTIONAL STUDIES OF EX VIVO CEREBRAL VESSELS. THIS WORK WILL UNCOVER NOVEL MOLECULAR MECHANISMS THAT CONTRIBUTE TO VASCULAR DEFECTS IN PAE AND WILL PROVIDE INSIGHT INTO RNA-BASED STRATEGIES THAT COULD BE DEVELOPED FOR IMPROVING PAE-MEDIATED EFFECTS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $336.3k | 5/15/25 | ||
| Not listed | $336.5k | 4/23/24 | ||
| Not listed | $336.5k | 4/23/24 |